Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-02-12 @ 2:00 AM
Study NCT ID:
NCT02169557
Status:
COMPLETED
Last Update Posted:
2020-06-24
First Post:
2014-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study
Sponsor:
Drugs for Neglected Diseases
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-15
First Submit QC Date:
None
Study First Post Date:
2014-06-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-23
Last Update Post Date:
2020-06-24
Last Update Post Date Type:
ACTUAL